AI assistant
Sending…
CEL SCI CORP — Director's Dealing 2016
Jan 14, 2016
34401_dirs_2016-01-14_4cd9791c-eddc-4bd0-adfb-d7b47f0ff9db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CEL SCI CORP (CVM)
CIK: 0000725363
Period of Report: 2016-01-13
Reporting Person: KERSTEN GEERT R (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-13 | Common Stock | A | 3000000 | $0.37 | Acquired | 11856706 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-13 | Series X Warrant | $0.37 | A | 3000000 | Acquired | 2021-01-13 | Common Stock (3000000) | Indirect |
Footnotes
F1: Includes 5,227,481 shares of common stock and warrants to purchase 5,844,627 shares of common stock held by the de Clara Trust. On January 13, 2016 the Company sold 3,000,000 shares of its common stock and warrants to purchase 3,000,000 shares of common stock to the de Clara Trust. The de Clara Trust is controlled by Geert Kersten, the Companys Chief Executive Officer and a director.
More from CEL SCI CORP
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Jan 26